---
layout: post
title: "Korelasi Tingkat Kepatuhan Konsumsi Obat Antiepilepsi Menggunakan Kuesioner MGLS (Morisky, Green, Levine Adherence Scale) dengan Frekwensi Kejang Pasien Epilepsi"
author: "Iin Ernawati, Wardah Rahmatul Islamiyah"
description: "Epilepsi merupakan penyakit gangguan kronis pada otak yang tidak menular yang dapat mempengaruhi orang dari segala usia OAE obat antiepilepsi merupakan terapi utama k"
categories: jfu
canonical_url: https://jurnal.harianregional.com/jfu/id-59758
comments: true
citation_abstract_html_url: "https://jurnal.harianregional.com/jfu/id-59758"
citation_pdf_url: "https://jurnal.harianregional.com/jfu/full-59758"
tags:

---

## Authors:
Iin Ernawati, Wardah Rahmatul Islamiyah

## Abstract:
"Epilepsi merupakan penyakit gangguan kronis pada otak yang tidak menular yang dapat mempengaruhi orang dari segala usia. OAE (obat antiepilepsi) merupakan terapi utama kebanyakan pasien epilepsi dengan tujuan keseluruhan adalah secara menyeluruh untuk mencegah terjadinya kejang tanpa menyebabkan efek samping. Salah satu ukuran manajemen terapi obat pada penyakit epilepsi adalah menurunnya/hilangnya kejang, sehingga frekwensi kejang menjadi salah satu ukuran pencapaian end outcome. Penelitian ini merupakan penelitian observasional cross sectional yang dilakukan pada pasien epilepsi rawat jalan poli syaraf Rumah Sakit Universitas Airlangga, yang bertujuan untuk melihat hubungan antara tingkat kepatuhan menggunakan obat antiepilepsi dengan kejadian kejang pada pasien epilepsi. Tingkat kepatuhan konsumsi OAE pada penelitian ini menggunakan kuesioner MGLS (Morisky, Green, Levine adherence Scale). Tingkat kepatuhan berdasarkan kuesioner MGLS dibagi menjadi 3 tingkatan diantaranya patuh rendah, menengah atau sedang dan patuh tinggi. Kejadian kejang pada pasien epilepsi yang diamati adalah ada atau tidaknya kejang selama sebulan terakhir, yang datanya diperoleh dari wawancara pasien atau keluarganya serta dari diary seizure. Hasil penelitian dari 40 responden diketahui terdapat korelasi positif sedang antara tingkat kepatuhan yang diukur menggunakan kuesioner MGLS yang mayoritas patuh sedang dengan adanya kejadian kejang pada pasien epilepsi (r = 0,423 dengan nilai p = 0,006 &lt;0,05)."

### Keywords
*Keyword Not Available*

### Downloads:
Download data is not yet available.

{% include adsense.html %}
## References
- 1.	M. J. Farrukh, M.M. Bakry, E. Hatah, H. J. Tan. “Use of complementary and alternative medicine and adherence to antiepileptic drug therapy among epilepsy patients: a systematic review” Patient Preference and Adherence vol. 12, p2111-2121. 2018
- 2.	J.P. Leach, R.J. Davenport, Neurological Disease. In : Walker, B.R., Colledge, N.R., Ralston, S.H., Penman, I.D. (Eds). Davidson’s Principles and Practice of Medicine 22 th ed. London : Churchill Livingstone Elsevier. 2014. p1137-2230
- 3.	M. Aminoff, V. Douglas, Nervous System Disorders. In : Papadakis, M. A., McPhee, S. J., Rabow, M. W. (Eds). Current Medical Diagnosis & Treatment 56th ed. New York : McGraw Hill Education. 2017. p 983-990
- 4.	WHO. World Health Organization Fact Sheet: Epilepsi, updated February. 2017. Available from: http://www.who.int/en/news-room/fact-sheets/detail/epilepsy
- 5.	Widyati, Soediatmoko, Z. Ikawati, L. Hakim, “Dampak Positif  Pelayanan  Farmasi Klinik Pada Pasien Epilepsi”. Jurnal  Manajemen  dan Pelayanan Farmasi, p217-222. 2013
- 6.	I.E. Leppik. Compliance in the treatment of epilepsi. In: The treatment of epilepsi. 2nd ed. Willie E, editor. Williams and Wilkins. 1997. p779-784
- 7.	M. Rasheva, I. Staikov, D. Svinarov, N. Mihnev, N. Neykov, M. Staneva, Low “Serum Levels of Antiepileptic Drugs in Patients with Epilepsy-Bad Compliance or Something Else?”. Austin J Clin Neurol; vol 2, no 10, p1083. 2015
- 8.	S. Al aqeel, J. Al-sabhan, M. Hiligsmann. “Strategies for improving adherence to antiepileptic drug treatment in people withepilepsy”. Cochrane Database of Systematic Reviews. 2. 2017
- 9.	C.A. Hovinga, M. R. Asato, R. Manjunath, J.W. Wheles, S.J. Phelps, R.D. Sheth. “Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: Survey of patients with epilepsy and physicians”. Epilepsy Behav, vol 13 no 2, p316–322. 2008
- 10.	D.E. Morisky, L.W. Green, D.M. Levine, Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care; vol. 24, p67–74. 1986
- 11.	H. Beyhaghi, B. B. Reeve, J. E. Rodgers, S. C. Stearns,  “Psychometric Properties of the Four-Item  Morisky  Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities Study (ARIC)  Participants”.  Value Health, vol. 19, no. 8, p996–1001. 2016
- 12.	A. M. Al qarni, T. Al rahbeni, A. Al qarni, H. M. Al qarni, “Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia – a cross-sectional survey”, Patient Preference  and  Adherence, vol. 13 63–71. 2019
- 13.	I. Ernawati, W.I. Islamiyah. “Uji Validitas Dan Reliabilitas Kuesioner Kepatuhan MGLS (Morisky, Green, Levine adherence Scale) Versi Bahasa Indonesia Terhadap Pasien Epilepsi”. Jurnal Ilmiah Ibnu Sina, vol. 4, no. 2, p305-313, 2019
- 14.	W.M. Gabr, M. Shams, “Adherence to medication among outpatient adolescents with epilepsy”. Saudi Pharmaceutical Journal, vol. 23, p33–40. 2015
- 15.	R. Manjunath, K.L. Davis, S. D. Candrilli, A. B. Ettinger, “Association of antiepileptic drug nonadherence with risk of seizure in adults with epilepsy”. Epilepsy Behaviour, vol 14, p372-378. 2009
- 16.	C.M. Ferrari, R.M. De Sousa, L.H. Castro.  “Factors associated with treatment non-adherence in patients with epilepsy in Brazil”. Seizure.  vol. 22, p384–389. 2013
- 17.	R.M. Jones, J.A. Butler, V.A. Thomas, R.C. Peveler, M. Prevett, “Adherence to treatment in patients with epilepsy: association with seizure control illness beliefs”. Seizure. vol. 15, p504-8. 2006
- 18.	A.J. Shallcross, A.B. Becker, A. Singh, D. Friendman, R. Jurd, J.A. French et al. “Psychosocial Factors Associated With Medication Adherence In Ethically And Socioeconomically Diverse Patients With Epilepsy.” Epilepsy Behav. Vol. 46, p242–245. 2015
- 19.	WHO. Adherence to long-term therapies: evidence for action . Diakses bulan Maret 2020. Diakses pada https://www.who.int/chp/knowledge/publications/adherence_report/en/
- 20.	E. Sabaté. Adherence to long-term therapies: evidence for action. World Health Organization. 2003
- 21.	D.Dash, T.M. Sebastian, M. Aggarwal, M. Tripathi. Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy & Behavior. Vol. 44, p213–17. 2015
- 22.	C.E. Elger, D. Schmidt. “Modern management of epilepsy: a practical approach”. Epilepsy Behav; vol. 12, p501-39. 2008
- 23.	G. O’Rourke, J.J. O’ Brien, J.J, “Review. Identifying the barriers to antiepileptic drug adherence among adults with epilepsy”. Seizure. 45. 2017
- 24.	Ernawati, I., Islamiyah, W.R., Sumarno. “How To Improve Clinical Outcome of Epileptic Seizure Control Based on medication Adherence? A Literature Review”. Open Access Macedonian Journal of Medical Sciences. vol. 6, no. 6, p1174-1179. 2018
- 25.	W. R. Islamiyah, Suharjono, H. P. Jaya, I. Ernawati, “Analysis Relationship of Self-Medication Card Administration with Adherence (ARMS Score), Phenytoin Serum Levels and Frequency of Seizures in Patients using Phenytoin Monotherapy”. Research Journal Of Pharmacy and Technology. Vol. 12, no.12, 2019
- 26.	A.M. Paschal, S.R. Hawley, T.S. Romain, E. Ablah. “Measures of adherence to epilepsy treatment: Review of present practices and recommendations for future directions”. Epilepsia, 49(7):1115–22. 2008
- 27.	J.D. Desai. “Epilepsy And Cognition”. J Pediatr Neurosci, 3, 16­27. 2008
- 28.	M.J. Connor. Epilepsy: Nature, Management, And Memory. Epilepsia, 24, 182­7. 1994
- 29.	G.A. Baker, A.J Hothersal, J.E Mallow. “Memory”. Epilepsy Action, vol. 10, p1­6. 2008

### PDF:

{% include adsense1.html %}

<https://jurnal.harianregional.com/jfu/full-59758>

{% include adsense2.html %}

### Published
2021-12-31

### How To Cite
ERNAWATI, Iin; ISLAMIYAH, Wardah Rahmatul.  Korelasi Tingkat Kepatuhan Konsumsi Obat Antiepilepsi Menggunakan Kuesioner MGLS (Morisky, Green, Levine Adherence Scale) dengan Frekwensi Kejang Pasien Epilepsi.Jurnal Farmasi Udayana, [S.l.], p. 121-125, dec. 2021. ISSN 2622-4607. Available at: <https://jurnal.harianregional.com/jfu/id-59758>. Date accessed: {{ site.time | date: "%d %b. %Y" }}. doi:https://doi.org/10.24843/JFU.2021.v10.i02.p02.

## Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

### Issue
Vol. 10, No 2, Tahun 2021

### Section 
**Articles**

### Copyright 
{% include inarticle.html %}
<a href="http://creativecommons.org/licenses/by/4.0/" rel="license"><img src="https://i.creativecommons.org/l/by/4.0/88x31.png" alt="Creative Commons License" /></a>
This work is licensed under a <a href="http://creativecommons.org/licenses/by/4.0/" rel="nofollow">Creative Commons Attribution 4.0 International License</a>

{% include multiplex.html %}
